Cencora Inc. (COR) - Total Liabilities
Based on the latest financial reports, Cencora Inc. (COR) has total liabilities worth $78.07 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore COR net asset momentum to track the company's year-over-year net asset growth rate.
Cencora Inc. - Total Liabilities Trend (1994–2025)
This chart illustrates how Cencora Inc.'s total liabilities have evolved over time, based on quarterly financial data. See Cencora Inc. (COR) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Cencora Inc. Competitors by Total Liabilities
The table below lists competitors of Cencora Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nike Inc
NYSE:NKE
|
USA | $22.97 Billion |
|
Electronic Arts Inc
NASDAQ:EA
|
USA | $6.37 Billion |
|
Suzhou Dongshan Precision Manufacturing Co Ltd
SHE:002384
|
China | CN¥40.15 Billion |
|
Sandvik AB
ST:SAND
|
Sweden | Skr81.89 Billion |
|
AutoZone Inc
NYSE:AZO
|
USA | $23.35 Billion |
|
Edwards Lifesciences Corp
NYSE:EW
|
USA | $2.99 Billion |
|
HOYA CORP. ADR/ 1 O.N.
F:HYB0
|
Germany | €262.65 Billion |
|
Discover Financial Services
NYSE:DFS
|
USA | $128.95 Billion |
Liability Composition Analysis (1994–2025)
This chart breaks down Cencora Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Cencora Inc. stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.95 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 22.98 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.96 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cencora Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cencora Inc. (1994–2025)
The table below shows the annual total liabilities of Cencora Inc. from 1994 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | $74.84 Billion | +12.86% |
| 2024-09-30 | $66.31 Billion | +7.15% |
| 2023-09-30 | $61.89 Billion | +9.56% |
| 2022-09-30 | $56.49 Billion | -0.47% |
| 2021-09-30 | $56.75 Billion | +25.80% |
| 2020-09-30 | $45.11 Billion | +23.72% |
| 2019-09-30 | $36.47 Billion | +4.28% |
| 2018-09-30 | $34.97 Billion | +5.16% |
| 2017-09-30 | $33.25 Billion | +5.53% |
| 2016-09-30 | $31.51 Billion | +15.22% |
| 2015-09-30 | $27.35 Billion | +39.70% |
| 2014-09-30 | $19.58 Billion | +17.93% |
| 2013-09-30 | $16.60 Billion | +27.81% |
| 2012-09-30 | $12.99 Billion | +7.19% |
| 2011-09-30 | $12.12 Billion | +5.53% |
| 2010-09-30 | $11.48 Billion | +5.75% |
| 2009-09-30 | $10.86 Billion | +14.18% |
| 2008-09-30 | $9.51 Billion | +3.23% |
| 2007-09-30 | $9.21 Billion | +6.57% |
| 2006-09-30 | $8.64 Billion | +21.72% |
| 2005-09-30 | $7.10 Billion | -2.93% |
| 2004-09-30 | $7.31 Billion | -8.96% |
| 2003-09-30 | $8.03 Billion | +1.75% |
| 2002-09-30 | $7.90 Billion | +5.96% |
| 2001-09-30 | $7.45 Billion | +242.45% |
| 2000-09-30 | $2.18 Billion | +14.89% |
| 1999-09-30 | $1.89 Billion | +28.25% |
| 1998-09-30 | $1.48 Billion | -14.66% |
| 1997-09-30 | $1.73 Billion | +41.30% |
| 1996-09-30 | $1.22 Billion | +25.70% |
| 1995-09-30 | $974.40 Million | -3.74% |
| 1994-09-30 | $1.01 Billion | -- |
About Cencora Inc.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order … Read more